Transsexual Erections Access

This overview addresses the physiological aspects of erections for transgender individuals, specifically focusing on how gender-affirming hormone therapy (GAHT) and various surgical procedures influence erectile function. Hormonal Effects on Native Genitalia

For transgender men (AFAB) who undergo phalloplasty (the surgical creation of a phallus), the new genitalia do not contain erectile tissue (corpora cavernosa) and cannot become erect on their own. To achieve rigidity for penetrative intercourse, an is typically implanted after the initial phallus has healed:

: While the physical mechanism of an erection may become less reliable, many report that arousal becomes a more "whole-body" or emotional experience rather than a purely localized physical response. Post-Surgical Erectile Function (Phalloplasty) transsexual erections

: When erections do occur, they are often less rigid than before hormone therapy.

If maintaining erectile function is a priority for someone on feminizing HRT, medical interventions are available: : Following surgery, sexual satisfaction is derived from

For transgender women who undergo vaginoplasty, the erectile tissue is typically reduced or repurposed.

: PDE5 inhibitors (like Sildenafil or Tadalafil) can often still be effective for trans feminine individuals. : Following surgery

: Following surgery, sexual satisfaction is derived from nerve sensitivity and pelvic engorgement rather than the maintenance of a rigid external erection. Medical Support and Management